Lunai Bioworks (LNAI) Other financing activities (2018 - 2024)
Lunai Bioworks (LNAI) posted quarterly Other financing activities of $280000.0 for Q4 2024, down 86.64% quarter-over-quarter from $2.1 million in Q3 2024.
Lunai Bioworks (LNAI) Other financing activities (2018 - 2024) Analysis & Trends
Lunai Bioworks' Other financing activities history runs 6 years deep, the most recent figure standing at $280000.0 for Q4 2024.
- In Q4 2024, Other financing activities changed N/A year-over-year to $280000.0; the TTM figure through Mar 2026 stood at $280000.0 (down 88.22% YoY), while the FY2025 annual figure was $2.4 million, up 595.06% from the prior year.
- Other financing activities for Q4 2024 stood at $280000.0, down from $2.1 million in the prior quarter.
- The five-year high for Other financing activities was $4.0 million in Q2 2021, with the low at -$1.7 million in Q1 2024.
- The 4-year median for Other financing activities is $1.6 million (2022), against an average of $1.4 million.
- The sharpest annual moves came in 2023 and 2024: Other financing activities advanced 23.08% in 2023, then slumped 161.16% in 2024.
- Lunai Bioworks' Other financing activities stood at $4.0 million in 2021, then sank by 59.38% to $1.6 million in 2022, then advanced by 23.08% to $2.0 million in 2023, then slumped by 86.0% to $280000.0 in 2024.
- Business Quant data shows LNAI's Other financing activities at $280000.0 in Q4 2024, $2.1 million in Q3 2024, and -$1.7 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 280,000.00 |
| Dec 31, 2024 | 280,000.00 |
| Sep 30, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 4.00 Mn |
| Mar 31, 2021 | 220,000.00 |
| Mar 31, 2021 | 220,000.00 |
| Sep 30, 2019 | 1.00 Mn |
| Sep 30, 2019 | 1.00 Mn |